Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia
Top Cited Papers
Open Access
- 9 June 2006
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 2 (6), e53
- https://doi.org/10.1371/journal.ppat.0020053
Abstract
Influenza A virus (IAV) is the etiological agent of a highly contagious acute respiratory disease that causes epidemics and considerable mortality annually. Recently, we demonstrated, using an in vitro approach, that the pattern recognition Toll-like receptor (TLR)3 plays a key role in the immune response of lung epithelial cells to IAV. In view of these data and the fact that the functional role of TLR3 in vivo is still debated, we designed an investigation to better understand the role of TLR3 in the mechanisms of IAV pathogenesis and host immune response using an experimental murine model. The time-course of several dynamic parameters, including animal survival, respiratory suffering, viral clearance, leukocyte recruitment into the airspaces and secretion of critical inflammatory mediators, was compared in infected wild-type and TLR3−/− mice. First, we found that the pulmonary expression of TLR3 is constitutive and markedly upregulated following influenza infection in control mice. Notably, when compared to wild-type mice, infected TLR3−/− animals displayed significantly reduced inflammatory mediators, including RANTES (regulated upon activation, normal T cell expressed and secreted), interleukin-6, and interleukin-12p40/p70 as well as a lower number of CD8+ T lymphocytes in the bronchoalveolar airspace. More important, despite a higher viral production in the lungs, mice deficient in TLR3 had an unexpected survival advantage. Hence, to our knowledge, our findings show for the first time that TLR3-IAV interaction critically contributes to the debilitating effects of a detrimental host inflammatory response. Influenza A virus (IAV) is responsible for highly contagious acute respiratory disease. Recent concerns have risen concerning a possible influenza pandemic in the near future. Thus, a better understanding of the molecular mechanisms of IAV pathogenesis and host immune responses is required for the development of more efficient means of prevention and treatment of influenza. The Toll-like receptor (TLR)3 is a member of a family of receptors that detects microbes and triggers host defenses. We previously demonstrated using an in vitro approach, that the TLR3 plays a key role in the response of lung epithelial cells to IAV. Here, we used a mouse model to dissect the in vivo importance of TLR3-dependent responses during influenza. The time-course of several parameters, including animal survival, respiratory distress, viral clearance, and inflammation, was compared in infected control wild-type and TLR3-deficient mice. Our findings reveal that TLR3−/− mice have an unexpected advantage against IAV challenge as we show for the first time that a reduction of TLR3-mediated inflammatory response reduces the clinical manifestations of IAV-induced pneumonia.Keywords
This publication has 53 references indexed in Scilit:
- Innate immune recognition of viral infectionNature Immunology, 2006
- Immune responses to dsRNA: Implications for gene silencing technologiesImmunology & Cell Biology, 2005
- Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A VirusJournal of Biological Chemistry, 2005
- Novel strategies for prevention and treatment of influenzaEmerging Therapeutic Targets, 2005
- The role of Toll-like receptors in the host response to virusesMolecular Immunology, 2005
- Viruses and Toll-like receptorsMicrobes and Infection, 2004
- Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lungClinical and Experimental Immunology, 2004
- Interferon γ Is Required for Activation-induced Death of T LymphocytesThe Journal of Experimental Medicine, 2002
- Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expressionCytokine & Growth Factor Reviews, 2001
- Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in miceAntiviral Research, 1998